Author

Ting Su

Donghua UniversityORCID 0000-0001-5254-1595Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Ting Su2 papers · Kunming University of Science and Technology

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Bo WeniD· 1 shared Chunpeng Yang· 1 shared Duxin SuniD· 1 shared Furong ChengiD· 1 shared Guizhi ZhuiD· 1 shared Guolan Xiao· 1 shared Hanning Wen· 1 shared Jinze LiuiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Bo WenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioengineeringbioRxivPreprintOct 1, 2024

Proteolysis-targeting vaccines (PROTAVs) for robust combination immunotherapy of melanoma

Qiyan Wang, Ting Su, Furong Cheng…·Guizhi Zhu

This paper introduces PROTAVs, a new vaccine strategy that enhances T cell responses and combination immunotherapy for melanoma by improving antigen processing and cross-presentation.

1 citation

mouseproteomics

𝕏 PostBluesky